You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?
  1. Ana Isabel Cachafeiro Pin1,
  2. Laura Villaverde Piñeiro2
  1. 1 Pharmacy, Hospital Da Costa, Burela, Galicia, Spain
  2. 2 Pharmacy, Hospital Comarcal de Monforte, Monforte de Lemos, Spain
  1. Correspondence to Ana Isabel Cachafeiro Pin, PHARMACY, Hospital Da Mariña, Burela, Galicia, Spain; ana.isabel.cachafeiro.pin{at}sergas.es

https://doi.org/10.1136/ejhpharm-2022-003657

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Among healthcare-related infections (HCRI), those caused by multidrug-resistant (MDR) bacteria are a major problem today. According to the O’Neill report,1 if this situation were to continue the number of deaths would increase from 700 000 to 10 million per year by 2050, even surpassing deaths from cancer. Klebsiella pneumoniae was responsible for 2–5% of HCRI in Spain between 2011 and 2014 and accounts for almost 8% at present.2 Recently, a global prevalence study found it is the most frequently isolated pathogen in ICUs (5–10%). High resistance percentages (close to 50%) have been observed for third-generation cephalosporins, penicillins associated with beta-lactamase and quinolone inhibitors and …

    View Full Text

    Footnotes

    • Twitter @anaicp, @lvilpin1

    • Contributors AICP and LVP designed the study and made primary contributions to data collection and assisted with data collection. All authors contributed to interpretation of results and revision of manuscript, and all approved the final manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.